Waist Circumference Is a Better Predictor than Body Mass Index of Coronary Heart Disease Risk in Overweight Premenopausal Women

Journal of Nutrition

Volumn 134, Issue 5, 2004, Pages 1071-1076

  Lofgren, Ingrid ^a   Herron, Kristin ^a   Zern, Tosca ^a   West, Kristy ^a   Patalay, Madhu ^a   Shachter, Neil S ^b   Koo, Sung I ^a   Fernandez, Maria Luz ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Howard Hughes Medical Institute   (United States)

Author keywords

Body mass index; Coronary heart disease; Overweight; Premenopausal women; Waist circumference

Indexed keywords

APOLIPOPROTEIN; BIOLOGICAL MARKER; GLUCOSE; INSULIN; LEPTIN; LIPID; LOW DENSITY LIPOPROTEIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EXERCISE; FEMALE; HUMAN; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PREMENOPAUSE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WALKING;

EID: 2442492742     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.5.1071     Document Type: Article

References (43)

1. Flegal, K. M., Carroll, M. D., Kuczmarski, R. J. & Johnson, C. L. (1998) Overweight and obesity in the United States: prevalence and trends, 1960-1994. Int. J. Obes. Relat. Metab. Disord. 22: 39-47.
2. Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S. & Marks, J. S. (2003) Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. J. Am. Med. Assoc. 289: 76-79.
3. Flegal, K. M., Carroll, M. D., Ogden, C. L. & Johnson, C. L. (1998) Prevalence and trends in obesity among US adults, 1999-2000. J. Am. Med. Assoc. 288: 1723-1727.
4. Mokdad, A. H., Serdula, M. K., Dietz, W. H., Bowman, B. A., Marks, J. S. & Koplan, J. P. (1999) The spread of the obesity epidemic in the United States, 1991-1998. J. Am. Med. Assoc. 282: 1519-1522.
5. Ross, R., Dagnone, D., Jones, P. J. H., Smith, H., Paddags, A., Hudson, R., & Janssen, I. (2000) Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. Ann. Intern. Med. 133: 92-103.
6. Virgin, S. E. & Schmitke, J. A. (2003) Metabolic syndrome. AAOHN 51: 28-37.
7. Wedick, N. M., Mayer-Davis, E. J., Wingard, D. L., Addy, C. L. & Barrett-Connor, E. (2001) Insulin resistance precedes weight loss in adults without diabetes. The Rancho Bernardo study. Am. J. Epidemiol 153: 1199-1205.
8. Shaefer, E. J. (2002) Lipoproteins, nutrition, and heart disease. Am. J. Clin. Nutr. 75: 191-212.
9. Lean, M. E. J., Han, T. S. & Morrison, C. E. (1995) Waist circumference as a measure for indicating need for weight management. Br. Med. J. 311: 158-161.
10. Janssen, I., Katzmarzyk, P. T. & Ross, R. (2002) Body mass index, waist circumference, and health risk: evidence in support of current National Institutes of Health guidelines. Arch. Intem. Med. 162: 2074-2079.
11. Ross, R. & Katzmarzyk, P. T. (2003) Cardiorespiratory fitness is associated with diminished total and abdominal obesity independent of body mass index. Int. J. Obes. 27: 204-210.
12. Craig, C. L., Marshall, A. L., Sjostrom, M., Bauman, A. E., Booth, M. L., Ainsworth, B. E., Pratt, M., Ekelund, U., Yngve, A., Sallis, J. F. & Oja, P. (2003) International physical activity questionnaire: 12-country reliability and validity. Med. Sci. Sports Exerc. 35: 1381-1395.
13. Allain, C. C., Poon, L. C., Chan, C. S., Richard, W. & Fu, P. C. (1974) Enzymatic determination of total serum cholesterol. Clin. Chem. 20: 470-475.
14. Wamick, G. R., Benderson, J. & Albers, J. J. (1982) Dextran-sulphate-Mg+2 precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin. Chem. 28: 1379-1388.
15. Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
16. Carr, T., Anderssen, C. J & Rudel, L. L. (1993) Enzymatic determination of triglycerides, free cholesterol, and total cholesterol in tissue lipid extracts. Clin. Biochem. 26: 39-42.
17. Rifai, N. & King, M. E. (1986) Immunoturbidimetric assays of apolipoproteins A-I, A-II and B in serum. Clin. Chem. 32: 957-960.
18. Frendenrich, A., Giroux, L. M., Tremblay, M., Krimbou, L., Davingnon, J. & Cohn, J. S. (1997) Plasma lipoprotein distribution of apo C-III in normolipidemic and triglyceridemic subjects: comparison of the apo C-III to apo E ratio in different lipoprotein fractions. J. Lipid Res. 38: 1421-1432.
19. Cohn, J. S., Tremblay, M., Amiot, M., Bouthillier, D., Roy, M., Genest, J. & Davignon, J. (1996) Plasma concentration of apolipoprotein E in intermediate-size remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects. Arterioscier. Thromb. Vasc. Biol. 16: 149-159.
20. Relijic, R., Ries, M., Anic, N. & Ries, B (1992) New chromogen for assay of glucose in serum. Clin. Chem. 38: 522-525.
21. Morgan, C. R. & Lazarow, A. (1963) Immunoassay of insulin; two antibody system; plasma insulin levels in normal, subdiabetic and diabetic rats. Diabetes 12: 115-126.
22. Abbey, M., Belling, G. B., Noakes, M., Hirata, F. & Nestel, P. J. (1993) Oxidation of low-density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation. Am. J. Clin. Nutr. 57: 391-398.
23. Markwell, M. A., Haas, S., Bieber, L., & Tolbert, N. E. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipopratein samples. Anal. Biochem. 87: 206-210.
24. Reaven, G.M. (1988) Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
25. American Diabetes Association (1998) Consensus development conference on insulin resistance. Diabetes Care 21: 310-314.
26. Haffner, S. M., Miettinen, H. & Stern, M. P. (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20: 1087-1092.
27. Ascaso, J. F., Romero, P., Real, J. T., Priego, A., Valdecabres, C. & Carmena, R. (2001) Insulin resistant quantification by fasting insulin plasma values and HOMA index in a non-diabetic population. Med. Cin. 117: 530-533.
28. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J. Am. Med Assoc. 285: 2486-2496.
29. Krauss, R. M. (1995) Dense low density lipoproteins and coronary artery disease. Am. J. Cardiol. 75: 53B-57B.
30. Parks, E. J. & Hellerstein, M. K. (2000) Carbohydrate-induced hypertriacylglycerolemia: historical perspective and review of biological mechanisms. Am. J. Clin. Nutr. 71: 212-433.
31. Herron, K. J., Vega-Lopez, S., Conde, K., Ramjiganesh, T., Roy, S., Shachter, N. & Fernandez, M. L. (2002) Pre-menopausal women classified as hypo- or hyper-responders, do not alter their LDL/HDL ratio following a high dietary cholesterol challenge. J. Am. Coll. Nutr. 21: 250-258.
32. Vega-Lopez, S., Conde, K., Vidal-Quintanar, R. L., Shachter, N. & Farnandez, M. L. (2002) Sex and hormonal status influence the effects of psyllium on lipoprotein remodeling and composition. Metab. Clin. Exp. 51: 500-507.
33. Jong, M. C., Hofker, M. H. & Havekes, L. M. (1999) Role of apoCs in lipoprotein metabolism: functional differences between apoC1, apoC2 and apoC3. Arterioscler. Thromb. Vasc. Biol. 19: 472-484.
34. Abbasi, F., McLaughlin, T., Lamendola, C., Yeni-Komshian, H., Tanaka, A., Wang, T., Nakajima, K. & Reaven, G. M. (1999) Fasting remnant lipoprotein cholesterol and triglyceride concentrations are elevated in nondiabetic, insulin resistant, female volunteers. J. Clin. Endocrinol. Metab. 84: 3903-3906.
35. Reaven, G. M. (2001) Insulin resistance: why is it important to treat? Diabetes Metab. 27: 247-253.
36. Abbasi, F., Brown, B. W., Jr., Lamendola, C., McLaughling, T. & Reaven, G. M. (2002) Relationships between obesity, insulin resistance and coronary heart disease risk. J. Am. Coll. Cardiol. 40: 937-943.
37. Rosamond, W. D., Cahambless, L. E. & Folsom, A. R. (1998) Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994. N. Eng. J. Med. 339: 861-867.
38. Shachter, N. S. (2001) Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr. Opin. Lipidiol. 12: 297-304.
39. Franklin, S. S., Larson, M. G., Khan, S. A., Wong, N. D., Leip, E. P., Kannel, W. B. & Levy, D. (2001) Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. 103: 1245-1249.
40. Schulz, L. O. & Schoeller, D.A. (1994) A compilation of total daily energy expenditures and body weights in healthy adults. Am. J. Clin. Nutr. 60: 676-681.
41. Tudor-Locke, C., Williams, J. E., Reis, J. P. & Pluto, D. (2002) Utility of pedometers for assessing physical activity: convergent validity. Sports Med. 32: 195-808.
42. Rooney B., Smalley K., Larson, J. & Havens, S. (2003) Is knowing enough? Increasing physical activity by wearing a pedometer. Wis. Med. J. 102: 31-36.
43. Scruggs, P. W., Beveridge, S. K., Esisenman, P. A., Watson, D. L., Shultz, B. B. & Randsell, L. B. (2003) Quantifying physical activity via pedometry in elementary physical education. Med. Sci. Sports Exerc. 35: 1065-1071.